GHK-Cu
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring human tripeptide that forms a stable complex with copper(II). It was first isolated from human plasma during studies comparing the biological activity of young plasma (ages 20–25) against older plasma (ages 50–70) on hepatic tissue function. Researchers observed that younger plasma more effectively preserved tissue health — specifically by suppressing fibrinogen synthesis — and traced this protective activity to the tripeptide GHK.
Overview
The fundamental activity of GHK-Cu appears to be gene regulation. Studies have shown it can reset the gene expression profiles of diseased cells — including cancer cells and cells from patients with COPD — toward patterns associated with healthier, younger tissue states. In dermatology and regenerative medicine, it is used as an adjunct therapy to support skin structure, wound healing, and collagen-dependent tissue repair. Its systemic activity also extends to bone, gastrointestinal mucosa, hair follicles, and the nervous system.
GHK-Cu (Copper Tripeptide) Specifications
| Component | Detail |
|---|---|
| GHK-Cu (Copper Tripeptide) | 15 mg lyophilized powder per vial |
| Reconstitution diluent | Bacteriostatic water for injection, 6 mL |
| Working concentration | 2.5 mg/mL post-reconstitution |
| Prescribed dose | 20 units (0.20 mL) = 500 mcg per injection |
Bacteriostatic water — preserved with 0.9% benzyl alcohol — is used rather than plain sterile water to permit multiple draws from a single reconstituted vial over the course of treatment without sterility compromise. Do not substitute unbacteriostatically preserved water.
Concentration: 15 mg / vial (lyophilized) R
econstitution: 6 mL bacteriostatic water → 2.5 mg/mL working solution Route: Subcutaneous injection Dose: 20 units (0.20 mL = 500 mcg) subcutaneously, once daily
Available: 15 mg lyophilized vial with bacteriostatic water diluent
This compound requires a valid prescription from a licensed healthcare provider. This product is not FDA-approved for any medical indication. Use is investigational and off-label.
Mechanism of Action
GHK-Cu works through several overlapping biological pathways that collectively support tissue integrity, cellular repair, and healthy gene expression.
Gene Expression Modulation
GHK-Cu's most significant documented mechanism is its capacity to influence gene activity at scale. Analysis of its effects on human gene expression has identified modulation of over 4,000 genes. Broadly, it upregulates genes associated with regeneration, repair, and anti-inflammatory signaling while downregulating genes linked to inflammation, cancer promotion, and tissue destruction. This pattern of gene reset has been observed in cancer cell lines — where GHK-Cu helped restore normal programmed cell death (apoptosis) pathways — and in COPD patient cells, where it suppressed destructive tissue remodeling genes and activated repair activity.
Fibrinogen Suppression
GHK-Cu was originally isolated for its ability to suppress fibrinogen synthesis in liver tissue. Fibrinogen is a clotting protein and a well-established biomarker of cardiovascular risk and systemic inflammation; elevated fibrinogen is independently associated with increased mortality. GHK-Cu's suppression of fibrinogen synthesis in early studies provided the first evidence of its systemic regulatory capacity.
Ubiquitin/Proteasome System Activation
The ubiquitin/proteasome system (UPS) is the cell's primary mechanism for identifying and degrading damaged, misfolded, or dysfunctional proteins. Accumulation of damaged proteins is a hallmark of cellular aging and neurodegeneration. GHK-Cu activates the UPS, supporting the clearance of protein debris and maintaining cellular proteostasis — the balance of protein production, folding, and degradation that keeps cells functioning properly.
DNA Repair Activation
GHK-Cu upregulates genes involved in DNA damage recognition and repair. Accumulated DNA damage is a primary driver of cellular aging, senescence, and malignant transformation. By enhancing the cell's repair machinery, GHK-Cu supports genomic stability over time.
Angiogenesis and Tissue Vascularization
The peptide stimulates the formation of new blood vessels, improving circulatory supply to tissues undergoing repair. Adequate vascularization is essential for sustained wound healing, nutrient delivery to regenerating tissue, and the maintenance of skin integrity in aged or photodamaged skin.
Collagen, Glycosaminoglycans, and Decorin Synthesis
GHK-Cu stimulates the synthesis of collagen — the primary structural protein of skin, tendons, bone, and connective tissue — along with glycosaminoglycans (GAGs) such as hyaluronic acid and chondroitin sulfate, which maintain hydration and tissue elasticity. It additionally stimulates decorin, a small proteoglycan that regulates collagen fibril diameter and organization. Proper decorin activity is associated with fine, well-organized collagen architecture — the structural basis of smooth, firm skin and resilient connective tissue.
Antioxidant and Anti-Inflammatory Effects
As a copper-binding peptide, GHK-Cu modulates the redox activity of copper ions, reducing their capacity to generate damaging free radicals while directing copper toward productive enzymatic functions. It also modulates inflammatory signaling pathways, reducing chronic low-grade inflammation (inflammaging) that drives much of the tissue damage associated with aging.
Nerve Outgrowth and Neuroprotection
GHK-Cu stimulates neuronal outgrowth and has been studied for neuroprotective effects relevant to age-related neurodegeneration. Neurons — with their high energy and oxygen demands — are particularly vulnerable to aging-associated gene dysregulation. GHK-Cu's ability to counter abnormal gene expression profiles in aging neural tissue positions it as a candidate for research in cognitive decline, though human clinical data in this area remains limited.
Mesenchymal Stem Cell Activation
GHK-Cu increases cellular stemness and stimulates the secretion of trophic factors by mesenchymal stem cells (MSCs). Trophic factors are signaling molecules that promote cell survival, proliferation, and differentiation — meaning GHK-Cu may help maintain the regenerative capacity of the stem cell compartment that tissues rely on for long-term self-repair.
Simple. Medical. Personalized.
Medical intake
Answer a few online questions about your health history, lifestyle, and goals — no clinic visits required.
Provider evaluation
A licensed medical professional reviews your intake and determines the safest, most effective option for you.
Personalized plan
Custom treatment plan built around your unique health needs, goals, medical history, and biology.
Ongoing support
Stay connected with your care team for follow-ups, adjustments, and expert answers — all online.
FAQs
Clinical Applications
GHK-Cu is used in integrative, anti-aging, and regenerative medicine as an adjunct peptide therapy. It does not replace conventional dermatological treatment, wound care, or oncological management. Clinical contexts in which providers incorporate GHK-Cu include:
Skin Aging and Rejuvenation: Reduction of fine lines, wrinkles, and skin laxity; improvement of firmness, elasticity, and clarity; smoothing of rough or textured skin; reduction of photodamage, mottled hyperpigmentation, sunspots, and lesions.
Wound Healing: Acceleration of healing in chronic or slow-healing wounds, post-procedural skin recovery, and repair of the skin's protective barrier proteins.
Hair and Scalp: Support for hair follicle health and follicular regeneration, particularly in the context of age-related thinning.
Gastrointestinal and Mucosal Repair: Support for healing of stomach and intestinal lining in conditions involving mucosal compromise.
Bone and Connective Tissue: Stimulation of collagen and GAG synthesis relevant to bone density and connective tissue integrity.
Systemic Anti-Aging and Inflammation Management: Reduction of chronic systemic inflammation, oxidative stress, and fibrinogen burden in patients with elevated cardiovascular or metabolic risk profiles.
Neurological Support: Adjunct use in protocols targeting age-associated cognitive decline, as part of neuroprotective programming; human data is preliminary.
All applications are off-label and investigational. Providers should discuss the experimental nature of GHK-Cu injectable therapy with patients before initiating treatment.
Dosage & Administration
Prescribed dose: 20 units (0.20 mL = 500 mcg) per injection Frequency: Once daily Route: Subcutaneous injection Recommended timing: Evening administration, to align with circadian-driven repair and regenerative activity during sleep Typical cycle: Provider-directed; commonly 4–12 weeks
Reconstitution Instructions:
Allow the lyophilized vial to reach room temperature before handling.
Draw 6 mL of bacteriostatic water into the provided syringe.
Insert the needle into the vial and inject the diluent slowly down the inner wall of the vial — do not inject directly onto the powder cake.
Gently swirl to dissolve. Do not shake — agitation can degrade peptide integrity.
The reconstituted solution should be clear. Do not use if cloudy, discolored, or particulate matter is visible.
Withdraw 20 units (0.20 mL) for each daily injection.
Swab the injection site with an alcohol wipe and allow to dry before injecting.
Administer subcutaneously in the abdomen or upper thigh. Rotate injection sites with each dose.
Precautions and Safety Information
This compound has not been approved by the FDA for any therapeutic indication. All clinical use is investigational. Long-term safety data from large-scale human trials is not established.
Contraindications and Caution:
Active malignancy: GHK-Cu's gene-modulating and angiogenic activity warrants caution in patients with active cancer. While preclinical data suggests GHK-Cu helps restore normal apoptosis in cancer cells, its use in oncology settings should be coordinated with the treating oncologist.
Copper metabolism disorders (Wilson's disease): GHK-Cu delivers bioavailable copper. Patients with impaired copper metabolism should not use this compound without specialist supervision.
Pregnancy and breastfeeding: Safety data is absent. Use is not recommended.
Pediatric use: Not studied in patients under 18. Safety and dosing are unknown.
Benzyl alcohol sensitivity: The bacteriostatic water diluent contains benzyl alcohol (0.9%). Patients with known benzyl alcohol sensitivity should not use this formulation.
Potential Side Effects: GHK-Cu has a well-established safety profile in topical applications and a favorable reported profile in injectable use. The following have been noted:
Injection site reactions: mild redness, bruising, or transient discomfort
Temporary skin flushing or warmth, consistent with local vasodilatory effects
Mild headache, reported occasionally
Transient fatigue during initial treatment days
Serious adverse effects have not been documented in available reports at therapeutic doses.
Contact your provider immediately if you experience: persistent or worsening injection site reaction, signs of systemic allergic response (hives, difficulty breathing, facial swelling), unusual neurological symptoms, or any symptoms that concern you.
Drug Interactions
Formal drug interaction studies for injectable GHK-Cu have not been conducted. The following considerations apply based on mechanism:
Copper-chelating agents (D-penicillamine, trientine): Agents used to reduce copper load in conditions such as Wilson's disease would directly antagonize GHK-Cu activity by chelating the copper component. Concomitant use is contraindicated without specialist guidance.
Antioxidant supplementation: High-dose exogenous antioxidants (e.g., high-dose vitamin C, NAC) may theoretically interact with the copper-mediated redox modulation central to GHK-Cu's mechanism. Clinical significance at standard supplemental doses is not established.
Immunosuppressants: GHK-Cu modulates immune and inflammatory gene expression; interactions with systemic immunosuppressive therapy cannot be excluded. Use in immunocompromised patients requires individualized provider evaluation.
No significant interactions with commonly prescribed peptide therapies, hormones, or compounded medications have been identified in available literature.
Storage
Before reconstitution (lyophilized vial):
Refrigerate at 36°F – 46°F (2°C – 8°C)
Protect from light; store in original packaging
Do not freeze
Use before labeled expiration date
After reconstitution (bacteriostatic water):
Refrigerate at 36°F – 46°F (2°C – 8°C)
Use within 28 days of reconstitution
Keep vial capped and away from direct light
Discard if solution becomes cloudy, discolored, or shows visible particulate matter
How It Works
FAQs
© 2026, TestosteroneShots.com PC
text (323)-283-9219
638 1/2 N Robertson Blvd, West Hollywood, CA 90069
The information and products provided on this website are for informational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All medical treatments are subject to evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and the use of any product carries potential risks and side effects that should be discussed with a qualified medical professional. These products are not approved by the FDA unless explicitly stated, and misuse or unauthorized sharing is strictly prohibited. By using this site or purchasing any service, you agree to our Terms of Service, Telehealth Consent, and Privacy Policy. We prioritize your privacy and comply with HIPAA regulations for protected health information. Services provided by licensed physicians/nurse practitioners in states served, e.g., CA, FL, and others, via telemedicine. Check your state's telemedicine laws. Must Be 18+ or Older to Qualify For Treatment.
